tirzepatide clinicaltrials gov Early‐Onset Obesity and Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials - Gourgari - 2025 - Obesity FDA Approves Tirzepatide, A Potential

"Because this was an observational study in a specific clinical population, randomized clinical trials are needed before GLP-1 medications can be recommended for treating addiction." The researchers plan to continue investigating the relationship between GLP-1 therapies and substance use behaviors through prospective studies that follow patients after they begin treatment, according to the study

| 06.08.26 | 9 min read

Navigating Insurance for Weight Loss Medications Starting on a weight loss journey with GLP-1 medications involves understanding insurance coverage

As lifestyle-related health challenges continue to rise, #innovations like these play a vital role in empowering better outcomes and long-term wellness

Table of Contents: How effective is semaglutide for weight loss

Efficiency Regular use of semaglutide helps not only to reduce weight, but also to reduce the risk of cardiovascular diseases, type 2 diabetes, reproductive disorders, joint and liver diseases